Clinical Trial Update: Renal Denervation by Allegro System in Patients With Resistant Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the Allegro Renal Denervation System for resistant hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Allegro Renal Denervation System

Snippet

Sponsor: Shanghai AngioCare Medical | Conditions: Renal Denervation, Resistant Hypertension | Phase 3 | Status: TERMINATED